Health Technology Assessment (Jun 2005)

A systematic review and economic evaluation of alendronate, etidronate, risedronate, raloxifene and teriparatide for the prevention and treatment of postmenopausal osteoporosis

  • M Stevenson,
  • M Lloyd Jones,
  • E De Nigris,
  • N Brewer,
  • S Davis,
  • J Oakley

DOI
https://doi.org/10.3310/hta9220
Journal volume & issue
Vol. 9, no. 22

Abstract

Read online

No abstracts available.